Biomarker predicts which stage II colon cancer patients may benefit from chemotherapy
Thursday, January 21, 2016 - 07:55
in Health & Medicine
A biomarker has been identified that predicts which stage II colon cancer patients may benefit from adjuvant chemotherapy to prevent a disease recurrence.